Reuters Pharma 2025: Pre-Conference Talks Featuring Mike Ryan
Mike Ryan Executive Vice President at Eversana shares a glimpse of his upcoming panel discussion at the Reuters Pharma 2025 event on “28 countries for 2 years: Explore and evaluate the trade-offs in European launch sequencing”
Mike elaborates on Eversana’s comprehensive offerings that help biopharmaceutical companies tap into the complex European market. He highlights the challenges facing the biopharma companies while navigating the regulatory landscape and HTAs standards set by the European countries.
By unlocking the infrastructure, including market access and pricing strategies, biopharma companies can seamlessly become commercial powerhouses.
Image Source: Canva
About the Author:
Mike Ryan
Related Post: Reuters Pharma 2025: Pre-Conference Talks Featuring Nazneen Rahman
Tags
Himanshu brings over 12 years of Pharma, Life Sciences, and Biotech expertise to Pharmashots. A self-proclaimed "Pharma Geek," his passion for the industry shines through. His career path blends hands-on lab research with high-level consulting at firms like PwC-Health Industries and Novartis. Himanshu holds a degree in Immunology from the University of Leeds, and boasts further credentials from IIM Lucknow and the London School of Economics. Connect with Himanshu to dive deeper into the dynamic world of pharmaceuticals and life sciences.
